PPT-M edicinal cannabis in
Author : aaron | Published Date : 2018-12-06
Victoria Dr Daniel Perkins Manager Research Strategy and Policy Office of Medicinal Cannabis Department of Health and Human Services Victoria Cannabis regulatory
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "M edicinal cannabis in" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
M edicinal cannabis in: Transcript
Victoria Dr Daniel Perkins Manager Research Strategy and Policy Office of Medicinal Cannabis Department of Health and Human Services Victoria Cannabis regulatory framework Victorian reform December . Cannabis contains a number of active substances like dronabinol THC and cannabidiol CBD THC is mainly responsible for the e64256ects of cannabis but others like CBD may also in64258uence the e64256ectiveness of the drug The chemical composition of YOUR NAME. Chapter Chairwoman. #. womengrow. CONNECT. EDUCATE. EMPOWER. Women Will Lead Cannabis Purchasing. Women make more than 80% of healthcare purchasing . decisions. Women account for 93% OTC pharmaceutical . Gabriel Handlarz. 6L 3I. From. . the. . President. . April. 18, 2014. . Marijuana. . Legalization. and Young . Brains. : Time . for. . Serious. . Study. Robert Dupont, M.D.; Jeffrey Lieberman, M.D. . Talking to your doctor, Safety and Update on Clinical Trials. Lubov. . Romantseva. , MD. Child Neurology and Epilepsy. Rush University Medical Center. Nov 12, 2016. Disclosures. I have no financial interest in any pharmaceutical company mentioned in this presentation. 11/. . 12. . /. . 16. Bob Morgan. Illinois Medical Cannabis Pilot Program Act. 2. Four . year pilot program beginning January 1, 2014 entitled the . “Illinois Compassionate Use of Medical . Cannabis Pilot Program . Presented by: Candice Beathard, PhD. December 15, 2015 . Background: History of Cannabis as Medicine . Dates back to 2727B.C. in China. 1. In U.S…. 1850: cannabis tinctures patented. 2. . 1963: chemical structure of cannabis identified. Presented by: Candice Beathard, PhD. December 15, 2015 . Background. 23 States and D.C. have enacted medical cannabis programs. 1. . 1. Marijuana Policy Project, 2015. . Background. State programs specify list of qualifying conditions. drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. he . Report of the Task Force on Cannabis Legalization and Regulation. For. Emerging Practices and Legal Context for Prescription Drugs and Marijuana in VAW Shelters. Susan Boyd, PhD, University of Victoria. Kanza Kaleem. Laboratory Operations. Ieso. , LLC. How does Medical and Recreational Differ?. In Medical States:. The number of people who can visit dispensaries is limited to certain illnesses. Require a medical card/certification authorized by a doctor and approved by the state.. Erik Messamore, MD, PhD. Associate Professor of Psychiatry, Northeast Ohio Medical University. Medical Director, Best Practices for Schizophrenia Treatment (BeST) Center. Overview. Cannabis association with acute psychosis is well-known. Jordan Tishler, MD. InhaleMD. MYTH: . Women aren’t interested. U.S. Women are sexually active. 65-70% - age 18-50 . - . Decreasing to 20-40% by age 90. Female Sexual Dysfunction = 40%. Male sexual dysfunction Is more . Gregg VandeKieft, MD, MA. WSHPCO “Expanding dimensions in hospice & palliative care”. Chelan, . wa. October 10, 2017. Disclosure. Dr. VandeKieft does not have any conflicts of interest to disclose. He will discuss medical applications of cannabis, but will not discuss off-label use of medications.. . and . synthetic . cannabinoids. . (“Spice”)?. Miriam Komaromy, MD. Associate Director, ECHO Institute . miriamk1@salud.unm.edu. overview. Cannabis. Epidemiology. Effects. Risks. Cannabis Use Disorder.
Download Document
Here is the link to download the presentation.
"M edicinal cannabis in"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents